Franz Rischard

3.9k total citations
57 papers, 743 citations indexed

About

Franz Rischard is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Franz Rischard has authored 57 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 27 papers in Cardiology and Cardiovascular Medicine and 7 papers in Epidemiology. Recurrent topics in Franz Rischard's work include Pulmonary Hypertension Research and Treatments (48 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Effects of Exercise (7 papers). Franz Rischard is often cited by papers focused on Pulmonary Hypertension Research and Treatments (48 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiovascular Effects of Exercise (7 papers). Franz Rischard collaborates with scholars based in United States, Italy and Germany. Franz Rischard's co-authors include Joe G. N. Garcia, Rebecca Vanderpool, Ankit A. Desai, Jason X.‐J. Yuan, Stephen M. Black, Aaron B. Waxman, Ayako Makino, Haiyang Tang, Ramon J. Ayon and Meredith Broderick and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Franz Rischard

50 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Franz Rischard United States	17	556	337	140	85	76	57	743
Taijyu Satoh Japan	16	273 0.5×	228 0.7×	272 1.9×	89 1.0×	43 0.6×	37	723
Fernando L. Martín United States	19	169 0.3×	848 2.5×	174 1.2×	129 1.5×	62 0.8×	34	1.1k
Thomas F. Lüscher Switzerland	11	210 0.4×	187 0.6×	155 1.1×	238 2.8×	97 1.3×	22	863
Vikram Gurtu Canada	10	519 0.9×	470 1.4×	340 2.4×	119 1.4×	102 1.3×	17	933
Yu-Juei Hsu Taiwan	12	193 0.3×	137 0.4×	363 2.6×	78 0.9×	102 1.3×	20	864
Freddy Romero United States	10	197 0.4×	58 0.2×	117 0.8×	86 1.0×	41 0.5×	18	565
Rangarajan D. Nadadur United States	14	191 0.3×	347 1.0×	317 2.3×	81 1.0×	29 0.4×	19	773
K Saji Japan	8	211 0.4×	203 0.6×	147 1.1×	62 0.7×	59 0.8×	17	423
Michael G. Risbano United States	14	250 0.4×	128 0.4×	107 0.8×	42 0.5×	102 1.3×	35	498
Yutaka Kakizoe Japan	14	110 0.2×	65 0.2×	283 2.0×	44 0.5×	50 0.7×	49	555

Countries citing papers authored by Franz Rischard

Since Specialization

Citations

This map shows the geographic impact of Franz Rischard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz Rischard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz Rischard more than expected).

Fields of papers citing papers by Franz Rischard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz Rischard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz Rischard. The network helps show where Franz Rischard may publish in the future.

Co-authorship network of co-authors of Franz Rischard

This figure shows the co-authorship network connecting the top 25 collaborators of Franz Rischard. A scholar is included among the top collaborators of Franz Rischard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz Rischard. Franz Rischard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

El‐Kersh, Karim, Remzi Bag, Neel S. Bhatt, et al.. (2025). Derivation of a simple risk calculator for predicting clinical worsening in patients with pulmonary hypertension due to interstitial lung disease. JHLT Open. 7. 100206–100206.

Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2025). Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension. Circulation Heart Failure. 18(8). e012912–e012912. 1 indexed citations

Varghese, Mathews Valuparampil, et al.. (2024). Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 327(4). L574–L586.

Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2024). Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. Journal of the American College of Cardiology. 84(22). 2196–2210. 6 indexed citations

Rischard, Franz, Natasha Altman, Jacqueline Szmuszkovicz, et al.. (2024). Long-Term Effects of COVID-19 on the Cardiopulmonary System in Adults and Children. CHEST Journal. 165(4). 978–989. 2 indexed citations

DuBrock, Hilary M., Robert P. Frantz, Gerald J. Beck, et al.. (2024). HEALTH-RELATED QUALITY OF LIFE AND NONINVASIVE METRICS OF RIGHT VENTRICULAR FUNCTION ACROSS THE SPECTRUM OF PULMONARY HYPERTENSION. CHEST Journal. 166(4). A5783–A5785.

Reddy, Yogesh N.V., Hilary M. DuBrock, Paul M. Hassoun, et al.. (2024). Non-Invasive Prediction of Pulmonary Vascular Disease-Related Exercise Intolerance and Survival in Non-Group 1 Pulmonary Hypertension. European Journal of Heart Failure. 26(11). 2323–2336. 1 indexed citations

Balasubramanian, Aparna, Evelyn M. Horn, Hilary M. DuBrock, et al.. (2024). Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension. CHEST Journal. 165(6). 1493–1504. 7 indexed citations

Martens, Pieter, Brett Larive, Barry A. Borlaug, et al.. (2023). Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. European Heart Journal. 44(22). 1979–1991. 17 indexed citations

10.

Naranjo, Mario, Erika B. Rosenzweig, Anna R. Hemnes, et al.. (2023). Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary Circulation. 13(3). e12281–e12281. 5 indexed citations

11.

Rahaghi, Farbod N., et al.. (2023). iCPET Calculator: A Web‐Based Application to Standardize the Calculation of Alpha Distensibility in Patients With Pulmonary Arterial Hypertension. Journal of the American Heart Association. 12(20). e029667–e029667. 5 indexed citations

12.

Rafikov, Ruslan, Franz Rischard, Mathews Valuparampil Varghese, et al.. (2022). Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex. Translational research. 247. 1–18. 9 indexed citations

13.

Nathan, Steven D., Victor F. Tapson, Jean Elwing, et al.. (2021). Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial. American Journal of Respiratory and Critical Care Medicine. 205(2). 198–207. 44 indexed citations

14.

Vanderpool, Rebecca, Kendall S. Hunter, Michael Insel, et al.. (2021). The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension. CHEST Journal. 161(4). 1048–1059. 16 indexed citations

15.

Sun, Xiaoguang, Belinda Sun, Aleksandra Babicheva, et al.. (2020). Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α. American Journal of Respiratory Cell and Molecular Biology. 63(1). 92–103. 45 indexed citations

16.

Simon, Marc A., Mardi Gomberg‐Maitland, Ronald J. Oudiz, et al.. (2019). PATIENTS WITH SEVERE PULMONARY ARTERIAL HYPERTENSION TREATED WITH ABI-009, NAB-SIROLIMUS, AN MTOR INHIBITOR: INTERIM RESULTS FROM A PHASE 1 CLINICAL TRIAL. Journal of the American College of Cardiology. 73(9). 1927–1927. 2 indexed citations

17.

Sinari, Shripad, Parinita Dherange, Balaji Natarajan, et al.. (2018). Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension. The American Journal of Medicine. 131(6). 702.e7–702.e13. 29 indexed citations

18.

Chakinala, Murali M., Jeremy P. Feldman, Franz Rischard, et al.. (2016). Transition from parenteral to oral treprostinil in pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 36(2). 193–201. 47 indexed citations

19.

Rischard, Franz, et al.. (2015). Selective Pulmonary Vasodilation Improves Ventriculovascular Coupling and Gas Exchange in a Patient with Unrepaired Single‐Ventricle Physiology. Pulmonary Circulation. 5(2). 407–411. 1 indexed citations

20.

Rischard, Franz, et al.. (2014). What’s new: the management of acute right ventricular decompensation of chronic pulmonary hypertension. Intensive Care Medicine. 40(12). 1930–1933. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact